Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4515]

Commissioner Olivér Várhelyi meets representatives from the cancer community to discuss Europe’s Beating Cancer Plan

Commissioner Olivér Várhelyi meets representatives from the cancer community to discuss Europe’s Beating Cancer...

Changing the way we think about metastatic brain cancer: New perspective calls for a bold shift in research and treatment

Changing the way we think about metastatic brain cancer: New perspective calls for a bold shift in research and...

EU's iBeChange initiative – A call to action on World Cancer Day

EU's iBeChange initiative – A call to action on World Cancer Day

Study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer

Study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer

Removing fallopian tubes during other abdominal surgeries may lower ovarian cancer risk

Removing fallopian tubes during other abdominal surgeries may lower ovarian cancer risk

Investigators pinpoint keys to cell therapy response for leukaemia

Investigators pinpoint keys to cell therapy response for leukaemia

Study succeeds in the early diagnosis of leptomeningeal disease in diffuse midline gliomas by liquid biopsy

Study succeeds in the early diagnosis of leptomeningeal disease in diffuse midline gliomas by liquid biopsy

A cancer call to action in South East Europe: A joint declaration to eliminate HPV cancers in all countries

A cancer call to action in South East Europe: A joint declaration to eliminate HPV cancers in all countries

HKU research identifies PICH protein as key player in preventing chromosome breakage linked to cancer

HKU research identifies PICH protein as key player in preventing chromosome breakage linked to cancer

FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer

FDA approves datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer

More from ecancer